Wereport a case of severe and fatal aplastic anemia during an episode of infectious mononucleosis caused by Epstein-Barr (EB) virus infection. The 13-year-old female patient had shown normal hematological findings and had previously undergone repeated chemotherapy and autologous bone marrowtransplantation for refractory non-Hodgkin malignant lymphoma(NHL). She was probably in an immuno-suppressed condition prior to this episode of infection. The possible causal relationship of the EB virus infection in the pathogenesis ofaplastic anemia was documented by the clinical course, demonstration ofEB virus genomein the bone marrow cells, and an elevated plasma interferon (IFN)-y level.
Introduction
The etiological agents of aplastic anemia are heterogeneous, and include chemicals, drugs, irradiation and viral infections (1) . However, most cases are idiopathic (1) . The viruses which can induce aplastic anemia include hepatitis virus, cytomegalovirus, Epstein-Barr (EB) virus, human immunedeficiency virus, and parvovirus B19 (2, 3) . However, most cases are diagnosed retrospectively based on indirect evidence such as the clinical manifestations, change in biochemistry, and rise in the levels of antibodies to the virus. Aplastic anemia caused by EB virus remains rare (3, 4) . It occurs even in healthy individuals after the clinical course of infectious mononucleosis; the prognosis of patients with aplastic anemia caused by EB virus is not necessarily poor (4) (5) (6) . However, fatal aplastic anemia has also been reported in previously healthy persons, immunodeficient patients, and in those with x-linked recessive lymphoproliferative disorders (4, (6) (7) (8) . Werecently treated a patient with fatal aplastic anemia after an episode of infectious mononucleosis caused by EB virus infection in a previously hematologically normal patient who had undergone repeated chemotherapy and autologous bone marrowtransplantation for refractory non-Hodgkinmalignant lymphoma.
Case Report A 13-year-old female visited our hospital on May 25, 1993 because of fever and productive cough, and was admitted on June 1. She had previously had large right neck lymph node swelling of approximately 6 cm in diameter, and small left neck, axillar and inguinal lymph node swelling on June 1988. The lymph node biopsy specimen revealed non-Hodgkin malignant lymphomaof the diffuse small cell type. The clinical stage was III by Ann Arbor classification (9) . Even after entering complete remission by repeated courses of combination chemotherapy consisting of cyclophosphamide, mitoxantrone, etoposide and prednisolone, the tumor approximately 5 cm in diameter relapsed at left neck in 1990 and 1991. Judged as being refractory to standard dose chemotherapy, the autologous bone marrow cells were harvested on September 1 99 1. The autologous bone marrow transplantation was performed on October 1992 at the third relapse following high-dose pre-conditioning chemotherapy with cytosine arabinoside, mitoxantrone and etoposide. The hematological recovery after transplantation was prompt. The clinical course after transplantation was favorable, and the patient was followed at the outpatient clinic until present admission. The chest X-ray on this admission revealed an infiltrative shadow of the lung which was diagnosed as acute pneumonia. Antibiotics were administered, and the pulmonary shadow improved gradually. Values for these parameters gradually becamenormal thereaf- value, 25%-56%), CD8 48.1% (17%-44%), CD4/CD8 ratio 1.05 (0.6-2.9). Aspirated bone marrow smear examination revealed hypocellular marrow with a markedly decreased number of normal hematopoietic cells with erythroid, myeloid, and megakaryocytic features; infiltration of atypical lymphocytes was observed. Severe anemia, fever and hemorrhagic episodes developed, despite the administration of antibiotics , granulocytecolony-stimulating factor (G-CSF) and blood cell transfusion including red cells and platelets. Immunoglobulin G was administered at the dose of2,500 mg/day for 5 days. However, the hematological findings did not improve, and the patient died due to pneumonia on the 32nd hospital day.
Materials and Methods
The Southern method of DNAanalysis of EB virus DNAin the bone marrow blood was performed by a previously described method ( 10) . DNAwas extracted from the bone marrow cells by phenol-chloroform extraction and ethanol precipitation. The DNAwas amplified by 30 cycles ofpolymerase chain reaction (PCR). The amplified DNAwas electrophoresed and then hybridized with synthetic oligonucleotide probes coding for the Bamregion of the EBvirus genome, and was detected as a 125 base pair band. In situ hybridization for EBvirus DNA in the bone marrow smears was performed using the ENZO Pathogene® DNAProbe Assay Kit (Enzo Diagnostics, Inc., Syosset, New York, USA).
The concentrations offollowing cytokines were measured in the peripheral blood plasma which was drawn on July 2, one day before death: erythropoietin (Epo) , granulocyte colony-stimulating factor (G-CSF) , granulocyte-macrophage-colony-stimulating factor (GM-CSF), interleukin (IL)-la, IL-3, interferon 
Results
EB-virus DNAwas detected in the patient's bone marrow blood using the Southern method of analysis (Fig. 2) , however, it was not detected in the bonemarrowcells in the aspirate smear by the in situ hybridization method. The concentrations of Epo, G-CSFand IFN-yin the peripheral blood plasma were elevated. Those of GM-CSF,IL-la, IL-3 and TNF-a were under detectable limits (Table 1) . Epo: erythropoietin, G-CSF: granulocyte-colony-stimulating factor, GM-CSF: granulocyte-macrophage-colony-stimulating factor, IL-1 a: interleukin-1 a, IL-3: interleukin-3, IFN-y: interferon-y, TNF-a: tumor necrosis factor-a.
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Permission to conduct an autopsy was not obtained, but that for necropsy of the bone marrow and liver was performed. The bone marrowspecimens demonstrated decreased bone marrow cell components, with infiltration of lymphocytes (Fig. 3) . The liver specimen showed infiltration of lymphocytes in the Glisson's sheath area (Fig. 4) .
Discussion
Infectious mononucleosis is, with rare exception, a selflimiting disease (6) . This patient first suffered from infectious mononucleosis, whenelevated liver enzymes, fever and pneumonia without peripheral blood cytopenia were observed, and aplastic anemia subsequently developed. The cause of the EB virus infection in this patient mayhave been chronic active infection, since an increase in anti-VCA IgG antibody and anti-EA antibody was observed (6) . This patient had previously received repeated chemotherapy and autologous bone marrow transplantation for the relapsed refractory malignant lymphoma, and had a low serum level ofIgG at admission, suggesting that she was in an immuno-suppressedcondition.
The reported hematological complications of EBvirus infection are hemolytic anemia, granulocytopenia, thrombocytopenia, aplastic anemia, and hemophagocytic syndrome (6) . The frequency ofEB virus-caused aplastic anemia is low (3, 4) ; EB virus DNAand protein were detected in only 1 of 40 patients with aplastic anemia studied retrospectively (4). The effect of viral infection on the suppressed hematopoiesis in patients with aplastic anemia is not fully understood (3, 4) . While the B cells are the recognized target ofEB virus infection, other cells mayalso harbor this virus (e.g., nasopharyngeal epithelial cells). Somehematopoietic cells may also be infected by EB virus (3, 4, 12) . EB virus nuclear antigen (EBNA) is detected by immunofluorescence and EB virus DNAis detected by in situ hybridization in B cell-depleted bone marrow cells (3 , 4) . EBvirus DNAis also observed in the monocyte-macrophage precursors (12) . The typical strains of EB virus are not inhibitory of normal hematopoiesis in vitro, but EB virus-exposed cells may be more susceptible to T cell-mediated cytotoxicity (3). However, the EB virus isolated from patients with aplastic anemia possesses molecular and biological properties associated with a cytolytic, non-transforming, strain in contrast to the typical, transforming, EB virus commonlyobtained from infected persons (4). The EB virus infects B-lymphocytes, as well as T-cells, and increases activated T-cells and cytotoxic T-cells, decreases helper T-cells, and increases production of IFN-y (3, 4) . These cellular and humoral effects on hematopoietic stem cells are considered to be involved in hematopoiesis suppression in aplastic anemia (13, 14) . Indeed, the concentration of IFN-y in the plasma of our patient was elevated along with the erytropoietin level which reflects the severity of anemia. The elevated level of G-CSF reflects the effect of G-CSF administration as well as endogenousproduction. Cytomegalovirus infection contributes to bonemarrowsuppression in somecases of allogeneic and autologous bone marrow transplantation ( 1 5).
Hematopoietic progenitor cells or accessory cells such as monocytes, T lymphocytes, fibroblasts and endothelial cells which are considered to provide growth factors maybe the target of infection either by direct lysis or by interfering with their function (15) .
It is often difficult to confirm that viral infection is the cause of aplastic anemia, since aplastic anemia is usually the end result of the disturbed hematopoiesis, by which time either the virus is not detected, or the virus infection is slight (4). In our patient, the process of development of aplastic anemia caused by EB virus infection was observed.
The viral DNAin the bone marrow blood could be demonstrated by the Southern method, in which DNAwas amplified with PCR. The demonstration of the EBvirus genome in the bone marrow blood might be a significant finding. However, the precise meaning in the pathogenesis of aplastic anemia remains unknown, since we could not localize the infected target cells in the bone marrowcells in the aspirate smear by the in situ hybridization method. This may have been due to the scarcity of bone marrowcells in the hypocellular marrowand the low sensitivity of the in situ hybridization method. Indeed, positivity for viral DNAhas been observed in only a small percentage of bone marrow cells (4) . EBvirus has been observed to be associated with lymphoproliferative and neoplastic diseases such as nasopharyngeal carcinoma, Burkitt's lymphoma, and non-Hodgkin B-cell and T-cell lymphoma. The infiltration of lymphocytes in the bone marrow and liver in the present patient would indicate the reactive proliferation of activated lymphocytes rather than the infiltration of malignant lymphoma cells.
With regard to treatment, antiviral agents and immunoglobulins have been reported to be effective (6) . Clinical trials have not shown acyclovir therapy to be effective in patients with acute infectious mononucleosis or with serious EBvirus infection associated with X-linked lymphoproliferative diseases (6, 16, 17 ). However, a reduced level of EB virus expression in bone marrow cells has been observed in some patients (4). We administered immunoglobulins, without effect, but did not administer acyclovir, since the clinical course was too rapid. Immuno-suppressive agents, such as anti-thymocyte globulin and cyclosporin A, may be effective for immune-mediated aplastic anemia (1 8) . Corticosteroids have been reported to be useful in EB virus-induced aplastic anemia (5), and hematological recovery has been observed in some patients. However,we did not administer these agents in the present patient because of the severe infection and possible immunosuppressed condition.
